FBInvestor
Stocks / Tg Therapeutics Inc
Institutional Ownership

Tg Therapeutics Inc

CUSIP 88322Q108COMTGTXQ1 2026

Institutional Holders
354
13F filers
Shares Held
89.29M
Aggregate institutional
Institutional Value
$2.91B
Q1 2026
Net New Holders
+13
59 new · 46 closed

Institutional Ownership Trend

Aggregate 13F value by quarter

Multi-quarter trend — upgrade to see history

Upgrade

Position Activity

Q1 2026

New positions59
Increased135
Decreased106
Sold out46

Institutional Holders

354 funds hold this security · Q1 2026

#FundSharesValueΔ SharesActivity
1Blackrock, Inc.22.25M$739.24M+404.5KAdded
2State Street Corp8.65M$287.35M+169.8KAdded
3Soleus Capital Management, L.P.4.03M$133.85M+890.0KAdded
4Geode Capital Management, LLC3.50M$116.29M+96.0KAdded
5Clearbridge Investments, LLC3.21M$106.67M237.1KReduced
6Goldman Sachs Group Inc2.29M$76.00M+236.6KAdded
7Congress Asset Management Co2.17M$72.02M+245.7KAdded
8Jane Street Group, LLC2.04M$67.82M+1.07MAdded
9Citadel Advisors LLC1.92M$63.88M+911.9KAdded
10Pictet Asset Management Holding SA1.75M$58.05M+286.3KAdded

344 more institutional holders on Premium

See every fund holding Tg Therapeutics Inc, with full quarter-over-quarter share changes.

Unlock all holders